Unknown OBSERVATIONAL NCT01814150

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome of Patients With Metastatic Cancer Treated With Docetaxel Based Chemotherapy

Sponsor: Gottfried Maya

Conditions Metastatic Bladder Cancer Metastatic Breast Cancer Metastatic Gastric Cancer Metastatic Lung Cancer Metastatic Prostate Cancer

Updated 8 times since 2017 Last updated: Mar 22, 2013 Started: Apr 30, 2013 Primary completion: Apr 30, 2016 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01814150, this observational or N/A phase trial focuses on Metastatic Bladder Cancer and Metastatic Breast Cancer and remains ongoing. Sponsored by Gottfried Maya, it has been updated 8 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status

▶ Show 3 earlier versions

May 2018 — Jun 2018 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Apr 2018 — May 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gottfried Maya

Data source: Meir Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kfar Saba, Israel